CM
CDMO

Castleark Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Castleark Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-195,893
Closed -$3.99M – 353
2022
Q1 		$3.99M Buy
195,893
+1,610
+0.8% +$32.8K 0.17% 127
2021
Q4 		$5.67M Sell
194,283
-33,754
-15% -$966K 0.21% 117
2021
Q3 		$4.92M Buy
228,037
+56,507
+33% +$1.36M 0.19% 126
2021
Q2 		$4.4M Buy
+171,530
New +$3.66M 0.15% 144

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Castleark Management's CDMO Position: Q2 2022 in Review

Castleark Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 195,893 shares — an estimated $3.99M sold.

Castleark Management first reported a position in CDMO in Q2 2021 and held it in 4 quarters. The position peaked at $5.67M in Q4 2021. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

  • Castleark Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Castleark Management sold 195,893 Avid Bioservices, Inc. Common Stock shares in Q2 2022, an estimated $3.99M.
  • Castleark Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Castleark Management's Avid Bioservices, Inc. Common Stock position peaked at $5.67M in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.